MYCN and central nervous system cancer: In addition, some subtypes of pediatric and young adult high‐grade gliomas, including those with MN1 alterations, MYCN amplifications, and H3‐3A G34 mutations, may be histologically indistinguishable from CNS embryonal tumors.2